Esophageal adenocarcinoma is the most common type of esophageal cancer seen in the United States and Western Europe. Barrett's esophagus (BE) is a well-known risk factor for esophageal adenocarcinoma and is believed to be found in 6% to 12% of patients undergoing endoscopy for gastroesophageal reflux disease and in more than 1% of all patients undergoing endoscopy. This article focuses on the pathogenesis, treatment, and prevention of BE.
|Original language||English (US)|
|Number of pages||18|
|Journal||Gastrointestinal Endoscopy Clinics of North America|
|State||Published - Jul 1 2008|
ASJC Scopus subject areas